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ABSTRACT
Objective: The object of this study was to develop a simple and inexpensive test for detection of
bacterial vaginosis (BV) in pregnant patients and to test its accuracy in a clinic population.
Methods: We developed a modified proline aminopeptidase (PAMP) assay to detect BV and
compared the results of the assay with the clinical diagnosis ofBV.
Results: The results of the PAMP assay in 55 asymptomatic and 50 symptomatic subjects
significantly correlated with a clinical diagnosis of BV. The prevalence ofBV in the asymptomatic
population was 42% (PAMP assay) and 38% (clinical diagnosis). In the symptomatic population, it
was 50% (PAMP assay) and 54% (clinical diagnosis). The sensitivity, specificity, accuracy, positive
predictive value (PPV), and negative predictive value (NPV) of the PAMP assay were 86, 85, 86,
78, and 91%, respectively, in asymptomatic patients and 89, 96, 92, 96, and 88%, respectively, in
symptomatic patients.
Conclusions: The modified PAMP assay, which we describe, met our goals for simplicity, cost, and
accuracy.We feel it could be best used as a screening test forBV in asymptomatic pregnant patients.
(C) 1994 Wiley-Liss, Inc.
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ecause of growing evidence
1-3 that bacterial
vaginosis (BV) may be a contributing factor in
preterm labor and delivery, a simple method for
detection ofBV is highly desirable. Schoonmaker et
al.
4 recently described a new method for the diag-
nosis of BV using a proline aminopeptidase
(PAMP) assay. They compared the Gram stain
with 2 PAMP assays using either L-proline
B-naphthyamide or L-proline P-nitroanalide as sub-
strate in the diagnosis ofBV. We have modified the
proline nitroanalide assay and report here the re-
suits of this modified assay in the diagnosis ofBV in
asymptomatic and symptomatic pregnant patients.
We chose the proline nitroanalide substrate because
proline naphthyamide yields a carcinogenic end
product.
SUBJECTS AND METHODS
Patients attended either the Teen or OB Clinic at
Richland Memorial Hospital. All patients seen in
these clinics were under the supervision of the au-
thor (J.L.B.) who made the clinical diagnoses. A
clinical diagnosis of BV, Trichomonas vaginitis
(TV), a yeast vaginitis (YV), or no vaginitis (NV)
was made using the following criteria: BV (3 or
more of the following: presence of 20% or more
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clue cells, fishy odor with KOH, vaginal
pH > 4.5, or thin gray-white discharge in patients
who were diagnosed with BV alone; 2 or more of
the following: presence of clue cells, fishy odor
with KOH, or vaginal pH > 4.5 in patients with
mixed infections); TV, presence of trichomonads
on wet mount; YV, presence of hyphae on wet
mount; and NV, absence of any diagnosis above.
All study patients were tested for BV, TV, and YV.
The PAMP assay was done in the following
manner. Vaginal secretions were taken with a cot-
ton-tipped applicator and placed in a 1.5 ml plastic
centrifuge tube containing 1.0 ml of normal saline.
The applicator tip was broken off and the tube was
sealed with a plastic cap which comes attached to the
tube. The tubes were placed in a refrigerator and
were assayed within 3 days of collection. The appli-
cator tip was removed from the tube with tweezers
and the secretions were extracted into the saline
using a gloved hand.
The tubes were centrifuged for 5 min at 10,000g
in a Fisher Scientific Microcentrifuge, Model 50-A
(Fair Lawn, NJ). The supernatant was decanted
and the following were added to the pellet in each
tube: 50 txl solution (0.05 M Trizma, T-4003,
pH 7.4) and 100 Il solution 2 (2 mg/ml of L-pro-
line p-nitroanalide, p-5267, made up in solution
1). A blank and a standard tube were run with each
batch of sample tubes. The blank tube contained
100 Ixl each of solutions and 2. The standard tube
contained 100 1 solution (containing 20 mU of
microsomal leucine aminopeptidase, L-5006, made
up in solution 1) and 100 Ixl solution 2. All chem-
icals were purchased from Sigma Chemical Com-
pany (St. Louis, MO). The reason 100 I1 of solu-
tion (blank tube) and 100 txl of enzyme (standard
tube) are added instead of 50 I1 is because the
volume of the pellet plus fluid remaining in the
sample tube after centrifugation and decantation is
about 50 I1. Therefore, all tubes contained approx-
imately 200 Ixl total volume for color development.
Leucine aminopeptidase was used as a standard be-
cause PAMP is not available commercially and
leucine aminopeptidase cleaves the proline from
proline nitroanalide in a similar manner as PAMP.
After the prepara.tion of the tubes (one or more
samples, one blank, and one standard), they were
incubated in a Dubnoff metabolic shaking incuba-
tor (Fisher Scientific, Norcross, GA) at 37C for
h. The samples were then removed, and the depth
of the yellow color was compared visually to the
standard and blank tubes. A positive test in a sam-
ple tube is a depth of color > the color in the
standard tube.
This method differs from the original method
described by Schoonmaker et al.
4 in the following
ways:
1. Sample collection, color development, and eval-
uation take place in the same tube. The original
method resuspends the cell pellet and transfers
it to a microtiter plate well.
2. A water incubator is used instead of an air incu-
bator.
3. Incubation time is reduced from 4 h to h.
4. A standard tube is used for comparison to the
sample tube. The original article states: "A yel-
low color indicated a diagnosis of bacterial vag-
inosis; a clear color was scored as negative for
bacterial vaginosis.
’’4
Statistical analyses were done using the X
2 test
for independence. P < 0.05 was considered signif-
icant.
RESULTS
All patients were pregnant at the time of the assay
with gestational ages ranging from first trimester to
41 weeks gestation. No attempt was made to control
for patient age or gestational age. Patients were
asked ifthey had any complaints ofvaginal burning
or itching or if they had an abnormal vaginal dis-
charge. Those who responded negatively were listed
as asymptomatic, while those who answered affir-
matively were listed as symptomatic.
A comparison of the results of the PAMP assay
with the clinical diagnoses of 55 asymptomatic preg-
nant patients is shown in Table 1. As can be seen,
there was a highly significant correlation between
the clinical diagnosis of BV and the PAMP assay.
Likewise, Table 2 illustrates a highly significant
correlation between the clinical diagnosis ofBV and
the PAMP assay in symptomatic patients.
Of the 105 subjects studied, 41 (39%) had BV
alone, 6 (5.7%) had BV plus TV, (1%) had BV
plus TV plus YV, 5 (4.8%) had TV alone, 9 (8.6%)
had YV alone, and (1%) had TV plus YV. There-
fore, in this population, 8 (7.6%) had mixed infec-
tions. Interestingly, all mixed infections were found
in symptomatic patients.
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TABLE I. Correlation between the clinical diagnosis
of BV, NV, TV, or YV and the PAMP assay in
asymptomatic pregnant patients
Clinical diagnosis (no. of patients)
PAMP assay BV positive* BV negative*
Postive 18 5
Negative 3 29
BV alone NV TV YV
Positive 18 4 0
Negative 3 25 2 2
*N 55;2 26; P < 0.001.
TABLE 2. Correlation between the clinical diagnosis
of BV, NV, TV, or YV and the PAMP assay in
symptomatic pregnant patients
Clinical diagnosis (no. of patients)
PAMP assay BV positive* BV negative*
Positive 24
Negative 3 22
BV BV BV + TV TV
alone +’IV +YV NV TV YV +YV
Positive 18
Negative 2
5 0 0 0
0 13 7
*N 50; X 35; P < 0.001.
TABLE 3. Sensitivity (Sen), specificity (Spec),
accuracy (Acc), PP, and NP of the PAMP assay in
asymptomatic and symptomatic pregnant patients
a
Asymptomatic Symptomatic
Sen (%) 86 89
Spec (%) 85 96
Acc (%) 85 92
PP (%) 78 96
NPV (%) 91 88
aSen true positive (TP) divided by TP + false negative (FN);
Spec true negative (TN) divided by TN + false positive (FP);
Acc= TP + TN divided by TP + TN + FP + FN; PPV TP divided
by TP + FP; NPV TN divided byTN + FN.
Table 3 illustrates the sensitivity, specificity,
accuracy, positive predictive value (PPV), and
negative predictive value (NPV) of the PAMP
assay.
DISCUSSION
When this study was established, our intention was
to set up a PAMP assay that was easy, inexpensive,
required no sophisticated equipment, demanded
minimum technical expertise, and was reasonably
accurate. The procedure described by Schoonmaker
et al.
4 seemed to serve as an excellent starting point.
The modified procedure as described here required
taking a specimen of vaginal fluid with a cotton
swab, extracting the fluid into saline in a centrifuge
tube, a 5 min centrifugation, decantation, making
measurement each of 50 I1 and 100 Ixl, a h
incubation in an ordinary water bath, and visually
reading a positive or negative test comparing the
sample to a standard.
In our study, the sensitivity of the PAMP assay
was 88% overall, which is comparable to that re-
ported for this assay by Shoonmaker et al.
4 (93%)
and Thomason et al. s (81%). Shoonmaker et al.
4
compared the PAMP assay with the Gram stain,
while Thomason et al.
5 compared the assay with the
clinical diagnosis of BV.
The data reported in Table 3 assume that the
clinical diagnosis ofBV is correct in every instance.
Since the clinical diagnosis of BV is based on sub-
jective evaluation, it is entirely possible that the
false-positive and the false-negative measurements
reported for the PAMP assay may not be truly
false-positive and false-negative values. Therefore,
the accuracy of the PAMP assay may actually be
better than we report here.
This would seem appropriate in light of the
report by Eschenbach et al.
6 They report that in
311 patients diagnosed with BV by Gram stain
criteria, 29% had a homogeneous discharge,
43% had a fishy odor with KOH, 97% had a
pH > 4.7, 81% had the presence of clue cells,
and 78% had 20% or more clue cells. However,
the PPV of the assay may be lower in a popula-
tion of patients with a lower prevalence of BV.
Perhaps it might be more appropriate not to
use terms such as sensitivity, specificity, and PPV
when conducting a study such as this. Neither of
the techniques used (clinical diagnosis, PAMP as-
say) provides a definitive diagnosis. Perhaps we
should only conclude that the techniques appear to
be evaluating the same process. The X
2 test for
independence illustrates that the odds the 2 mea-
surements (clinical diagnosis, PAMP assay)are
totally independent of one another are less than in
1,000.
While the assay could be used in a variety of
settings, we feel that a definite role would be its
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potential use as a screening test in asymptomatic
pregnant clinic patients. This may be particularly
applicable to public health settings. In our study in
this population, 38% (by clinical diagnosis) and
42% (by positive PAMP assay) were found to be
harboring the organisms associated with BV.
While the assay described takes longer to com-
plete than a clinical diagnosis by a physician, the
assay can be performed by non-physician per-
sonnel with minimal training in laboratory medi-
cine. In addition, it appears that the assay will
detect BV in the asymptomatic patient who would
not normally be checked for BV in a clinical set-
ting. This may be particularly pertinent in view of
the recent data reported by Riduan et al.
7 They
showed that preterm delivery was more prevalent
in patients with BV diagnosed at 16-20 weeks ges-
tation but not in patients diagnosed with BV at
28-32 weeks gestation. Perhaps screening a large
group of asymptomatic patients with the PAMP
assay at 16-20 weeks gestation would yield promis-
ing results.
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